Advertisement

PATHFINDER study: Galleri blood test can detect cancers before symptoms arise

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Results from the interventional PATHFINDER study evaluating Galleri, a multi-cancer early detection (MCED) blood test, show that the blood test can detect cancers before symptoms arise.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).
Advertisement
Advertisement